| 派林生物 (000403) 财务指标 | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 每股收益 | 每股净资产 | 每股经营性 现金流 |
每股公积金 | 每股 未分配利润 |
总资产 利润率 |
主营业务利润率 | 总资产净利润率 | 成本费用利润率 | 营业利润率 | 主营业务 成本率 |
主营利润 比重 |
净资产 收益率 |
主营业务 收入增长率 |
净利润 增长率 |
总资产 增长率 |
应收帐款 周转率 |
存货周转 天数 |
存货周转率 | 总资产周转率 | 股东权益 周转率 |
流动比率 | 速动比率 | 现金比率 | 股东权益 比率 |
长期负债 比率 |
股东权益与 固定资产比率 |
资产负债率 | 经营现金净流量 对销售收入比率 |
资产的经营现金流 量回报率 |
经营现金净流量与 净利润的比率 |
经营现金净流量 对负债比率 |
现金流量比率 |
| 2025-09-30 | 0.38 | 8.45 | -0.1 | 4.7758 | 2.4977 | 3.7336 | 45.4137 | 3.7988 | 34.6849 | 26.664 | 180.5833 | 4.45 | -14.3958 | -34.1333 | 5.7656 | 2.5369 | 0.5861 | 0.1719 | 0.2031 | 2.9342 | 1.5888 | 44.7626 | 83.7494 | 2.0602 | -- | 16.2506 | -0.0596 | -0.0101 | -0.2699 | -0.062 | -7.4995 | ||
| 2025-06-30 | 0.38 | 8.45 | -0.1 | 4.7758 | 2.3713 | 2.5978 | 46.7042 | 2.5744 | 38.8201 | 28.9642 | 171.3191 | 4.45 | -13.1754 | -27.8488 | 2.7682 | 1.6336 | 0.3646 | 0.1077 | 0.1248 | 3.6732 | 1.9024 | 61.8433 | 86.9649 | 2.3993 | 449.8602 | 13.0351 | -0.1953 | -0.0212 | -0.8167 | -0.1628 | -21.3115 | ||
| 2025-03-31 | 0.38 | 8.45 | -0.1 | 6.5085 | 3.2353 | 0.9671 | 46.9474 | 0.9645 | 38.8063 | 29.3254 | 170.1666 | 4.45 | -14.0003 | -27.0208 | 5.4933 | 0.6717 | 0.1458 | 0.0406 | 0.0471 | 4.1911 | 2.4557 | 80.4791 | 87.0578 | 3.206 | -- | 12.9422 | -0.3092 | -0.0126 | -1.3025 | -0.0973 | -13.9925 | ||
| 2024-12-31 | 0.38 | 8.45 | -0.1 | 6.5085 | 3.1135 | 8.0578 | 48.3003 | 8.3353 | 48.4381 | 33.1607 | 150.3581 | 4.45 | 13.9974 | 21.8439 | 7.1351 | 4.3706 | 1.2605 | 0.297 | 0.3461 | 3.7399 | 2.4512 | 138.0526 | 85.6292 | 3.2794 | 539.2461 | 14.3708 | 0.1212 | 0.0348 | 0.4319 | 0.2422 | 33.6259 | ||
| 2024-09-30 | 0.38 | 8.45 | -0.1 | 6.5431 | 3.0134 | 5.9952 | 49.6978 | 6.1385 | 50.22 | 33.7917 | 151.6304 | 4.45 | 37.4925 | 66.5857 | 9.8077 | 3.2739 | 0.9132 | 0.2138 | 0.248 | 4.0648 | 2.7576 | 86.5432 | 86.4315 | 2.9959 | -- | 13.5685 | 0.1204 | 0.0251 | 0.4192 | 0.1852 | 26.1096 | ||
| 2024-06-30 | 0.38 | 8.45 | -0.1 | 6.5431 | 2.7191 | 3.7002 | 49.3638 | 3.7439 | 50.2182 | 33.6652 | 151.2353 | 4.45 | 60.2346 | 128.6528 | 9.2662 | 2.0713 | 0.5523 | 0.1301 | 0.1512 | 3.7163 | 2.4778 | 92.4118 | 86.1076 | 2.5184 | 709.2651 | 13.8924 | 0.0993 | 0.0128 | 0.3452 | 0.0919 | 12.2649 | ||
| 2024-03-31 | 0.38 | 8.45 | -0.1 | 6.5384 | 2.6715 | 1.3979 | 50.377 | 1.405 | 50.9541 | 34.2287 | 155.7028 | 4.45 | 67.0016 | 116.7795 | 9.9923 | 0.8148 | 0.2101 | 0.0502 | 0.0582 | 4.0064 | 2.7204 | 115.064 | 86.5418 | 2.6125 | -- | 13.4582 | -0.119 | -0.0059 | -0.4256 | -0.0442 | -6.0369 | ||
| 2023-12-31 | 0.38 | 8.45 | -0.1 | 6.5388 | 2.5042 | 7.085 | 50.5493 | 7.3615 | 44.1149 | 29.8527 | 171.0709 | 4.45 | -3.1792 | 4.0467 | 8.1198 | 3.2811 | 1.474 | 0.2804 | 0.3261 | 3.7151 | 2.729 | 154.9944 | 85.996 | 2.2719 | 782.1501 | 14.004 | 0.2916 | 0.0787 | 1.1104 | 0.5618 | 73.6294 | ||
| 2023-09-30 | 0.38 | 8.45 | -0.1 | 6.5324 | 2.113 | 3.9518 | 49.1964 | 4.0157 | 37.7811 | 27.1044 | 182.7657 | 4.45 | -7.9452 | -7.0552 | 9.2302 | 2.019 | 0.8687 | 0.1694 | 0.1965 | 3.637 | 2.5038 | 92.5825 | 86.4718 | 2.0303 | -- | 13.5282 | 0.1642 | 0.0274 | 0.6928 | 0.2024 | 26.7222 | ||
| 2023-06-30 | 0.38 | 8.45 | -0.1 | 6.533 | 1.8662 | 1.7682 | 47.8125 | 1.7798 | 29.3438 | 22.757 | 212.7827 | 4.45 | -28.4526 | -35.4664 | 8.4881 | 1.0953 | 0.4798 | 0.0883 | 0.1028 | 3.3332 | 2.3546 | 97.6962 | 85.7234 | 1.7741 | 761.43 | 14.2766 | 0.2205 | 0.0193 | 1.0936 | 0.1354 | 17.1752 | ||
| 2023-03-31 | 0.38 | 8.45 | -0.1 | 6.5323 | 1.8331 | 0.7093 | 47.3318 | 0.7068 | 30.8363 | 24.2174 | 196.243 | 4.45 | -47.8718 | -46.9657 | 9.5629 | 0.4023 | 0.1906 | 0.0328 | 0.0378 | 3.7403 | 2.7521 | 121.9526 | 87.3736 | 1.2537 | -- | 12.6264 | 0.4085 | 0.0134 | 1.8956 | 0.1065 | 13.3495 | ||
| 2022-12-31 | 0.38 | 8.45 | -0.1 | 6.5253 | 1.7568 | 7.3624 | 51.4284 | 7.7994 | 39.3566 | 27.5833 | 187.3054 | 4.45 | 21.9834 | 50.0971 | 12.6207 | 3.508 | 1.69 | 0.3192 | 0.3647 | 3.1762 | 2.5261 | 104.3248 | 85.954 | 0.6625 | 780.0426 | 14.046 | 0.218 | 0.0657 | 0.892 | 0.4676 | 54.6455 | ||
| 派林生物 (000403) 利润表 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 营业收入 | 营业支出 | 销售费用 | 管理费用 | 财务费用 | 营业利润 | 利润总额 | 净利润 | ||||
| 2025-09-30 | 161814.65 | 120415.03 | 17906.79 | 13855.39 | -2766.96 | 43146.27 | 40693.70 | 35749.73 | ||||
| 2025-06-30 | 98648.18 | 71156.16 | 9447.67 | 9287.55 | -2034.59 | 28572.67 | 26893.01 | 23591.68 | ||||
| 2025-03-31 | 37464.96 | 27648.08 | 3197.00 | 4574.98 | -1012.70 | 10986.74 | 10336.23 | 8893.95 | ||||
| 2024-12-31 | 265468.46 | 181572.84 | 24460.37 | 19265.49 | -4916.99 | 88031.30 | 85277.81 | 74504.22 | ||||
| 2024-09-30 | 189026.53 | 127963.94 | 18868.52 | 13108.04 | -3694.63 | 63875.22 | 61954.65 | 54275.85 | ||||
| 2024-06-30 | 113617.82 | 77212.16 | 10299.04 | 8512.89 | -2495.48 | 38249.69 | 37085.28 | 32697.58 | ||||
| 2024-03-31 | 43564.07 | 29748.55 | 3395.65 | 3994.35 | -1345.73 | 14911.40 | 14094.97 | 12186.98 | ||||
| 2023-12-31 | 232872.33 | 163949.55 | 28556.70 | 18024.61 | -5757.18 | 69518.76 | 68810.88 | 61147.25 | ||||
| 2023-09-30 | 137481.33 | 103326.98 | 20225.72 | 12164.80 | -4285.08 | 37263.56 | 37006.90 | 32581.33 | ||||
| 2023-06-30 | 70907.18 | 57234.93 | 12101.34 | 8130.76 | -2939.28 | 16136.35 | 15932.93 | 14300.10 | ||||
| 2023-03-31 | 26086.03 | 21830.96 | 4143.35 | 3886.26 | -1365.12 | 6317.35 | 6291.69 | 5621.83 | ||||
| 2022-12-31 | 240518.84 | 175333.41 | 39956.88 | 16547.70 | -5531.49 | 66342.95 | 66039.21 | 58769.01 | ||||
| 派林生物 (000403) 资产负债表 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 货币资金 | 应收帐款 | 预付款项 | 其它应收款 | 流动资产合计 | 非流动资产合计 | 资产总计 | 流动负债合计 | 非流动负债合计 | 负债合计 | 股东权益合计 | 负债及股东权益总计 |
| 2025-09-30 | 57590.21 | 64444.50 | 3129.95 | -- | 580019.10 | 580019.10 | 957519.12 | 26945.39 | 26945.39 | 155602.44 | 802594.87 | 957519.12 |
| 2025-06-30 | 55908.66 | 57651.67 | 2615.83 | 522.65 | 576060.06 | 576060.06 | 908129.61 | 27971.79 | 27971.79 | 118375.54 | 790456.49 | 908129.61 |
| 2025-03-31 | 66625.99 | 48428.95 | 5149.93 | -- | 572705.10 | 572705.10 | 919670.08 | 36239.26 | 36239.26 | 119025.94 | 801373.93 | 919670.08 |
| 2024-12-31 | 132112.43 | 63122.18 | 2301.14 | 452.80 | 566732.08 | 566732.08 | 924626.94 | 37179.50 | 37179.50 | 132876.67 | 792465.08 | 924626.94 |
| 2024-09-30 | 75418.66 | 57117.59 | 4606.08 | -- | 551088.88 | 551088.88 | 905321.63 | 35693.28 | 35693.28 | 122838.94 | 783171.08 | 905321.63 |
| 2024-06-30 | 85034.93 | 51351.30 | 2183.22 | 1210.71 | 541700.80 | 541700.80 | 883667.73 | 30745.00 | 30745.00 | 122762.40 | 761597.14 | 883667.73 |
| 2024-03-31 | 98850.91 | 48570.45 | 4603.94 | -- | 527589.64 | 527589.64 | 871780.70 | 31416.14 | 31416.14 | 117325.68 | 755153.85 | 871780.70 |
| 2023-12-31 | 142935.00 | 58357.87 | 2673.59 | 1308.58 | 520439.94 | 520439.94 | 863047.41 | 28641.56 | 28641.56 | 120861.02 | 742864.93 | 863047.41 |
| 2023-09-30 | 78208.15 | 52601.85 | 2999.81 | -- | 517225.45 | 517225.45 | 824460.92 | 27060.93 | 27060.93 | 111534.96 | 713533.77 | 824460.92 |
| 2023-06-30 | 88954.60 | 45893.11 | 4376.67 | 3652.94 | 505235.98 | 505235.98 | 808729.06 | 24406.50 | 24406.50 | 115458.77 | 693853.50 | 808729.06 |
| 2023-03-31 | 97351.03 | 46087.80 | 7349.73 | -- | 494008.02 | 494008.02 | 792583.07 | 20248.13 | 20248.13 | 100075.05 | 693093.49 | 792583.07 |
| 2022-12-31 | 100079.71 | 83587.70 | 5756.72 | 3247.92 | 493534.87 | 493534.87 | 798232.45 | 16188.83 | 16188.83 | 112119.72 | 686752.42 | 798232.45 |
| 派林生物 (000403) 现金流量表 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公告日期 | 经营活动现金流入小计 | 经营活动现金流出小计 | 经营活动产生的现金流量净额 | 投资活动现金流入小计 | 投资活动现金流出小计 | 投资活动产生的现金流量净额 | 取得借款收到的现金 | 发行债券收到的现金 | 筹资活动现金流入小计 | 筹资活动现金流出小计 | 筹资活动产生的现金流量净额 | |
| 2025-09-30 | 167590.99 | 177239.68 | -9648.68 | 93487.57 | 151027.96 | -57540.39 | 53431.87 | -- | 53436.87 | 60999.77 | -7562.89 | |
| 2025-06-30 | 98643.71 | 117910.10 | -19266.39 | 70012.12 | 103805.74 | -33793.62 | 25815.17 | -- | 25815.17 | 49174.78 | -23359.61 | |
| 2025-03-31 | 50410.92 | 61994.86 | -11583.93 | 5762.93 | 60434.68 | -54671.76 | 12029.32 | -- | 12029.32 | 11217.40 | 811.92 | |
| 2024-12-31 | 254899.38 | 222720.34 | 32179.04 | 191066.16 | 224659.76 | -33593.60 | 57181.40 | -- | 58607.89 | 67982.37 | -9374.47 | |
| 2024-09-30 | 189864.18 | 167110.76 | 22753.42 | 100438.76 | 184593.69 | -84154.92 | 35208.30 | -- | 36632.61 | 42697.67 | -6065.06 | |
| 2024-06-30 | 122686.18 | 111400.35 | 11285.83 | 75948.99 | 134089.45 | -58140.47 | 21240.10 | -- | 22662.59 | 33688.44 | -11025.85 | |
| 2024-03-31 | 56447.49 | 61633.73 | -5186.24 | 18189.66 | 62226.85 | -44037.19 | 11767.50 | -- | 11767.50 | 6607.59 | 5159.91 | |
| 2023-12-31 | 258752.38 | 190851.75 | 67900.63 | 83650.26 | 112571.39 | -28921.13 | 43832.29 | -- | 44662.17 | 40838.48 | 3823.69 | |
| 2023-09-30 | 165273.34 | 142700.02 | 22573.32 | 52932.71 | 100203.90 | -47271.18 | 38004.90 | -- | 38689.28 | 35844.07 | 2845.22 | |
| 2023-06-30 | 103193.11 | 87554.67 | 15638.44 | 32021.91 | 65752.54 | -33730.63 | 27913.30 | -- | 27983.30 | 20998.69 | 6984.61 | |
| 2023-03-31 | 56285.81 | 45629.33 | 10656.47 | 13012.38 | 30179.31 | -17166.93 | 12074.45 | -- | 12145.14 | 8335.19 | 3809.94 | |
| 2022-12-31 | 209526.38 | 157104.49 | 52421.89 | 44766.40 | 100404.10 | -55637.70 | 48179.14 | -- | 48430.10 | 33584.09 | 14846.01 | |
| 派林生物 (000403) 最新业绩预告 查看：历史业绩预告 | |
|---|---|
| 公告日期 | 2024-10-10 |
| 报告期 | 2024-09-30 |
| 类型 | |
| 业绩摘要 | 预计2024年1-9月归属于上市公司股东的净利润为：52191万元至55453万元，与上年同期相比变动幅度：60%至70%。 |
| 上年同期每股收益(元) | 0.446 |
| 行业 | 生物制品 |
| 概念 | 血制品,股权争夺,ST摘帽 |
| 账务标签 | 白马股 |
| 账务评述 | |